Sareum (SAR) Competitors GBX 14.30 +0.30 (+2.14%) As of 06/13/2025 11:21 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock SAR vs. PHD, FEN, NMT, TSI, CGO, MYN, IDE, EVG, PCF, and NCAShould you be buying Sareum stock or one of its competitors? The main competitors of Sareum include Proactis (PHD), Frenkel Topping Group (FEN), Neometals (NMT), Two Shields Investments Plc (TSI.L) (TSI), Contango (CGO), Mayan Energy (MYN), IDE Group (IDE), Evgen Pharma (EVG), PCF Group (PCF), and New Century AIM VCT (NCA). These companies are all part of the "financial services" industry. Sareum vs. Its Competitors Proactis Frenkel Topping Group Neometals Two Shields Investments Plc (TSI.L) Contango Mayan Energy IDE Group Evgen Pharma PCF Group New Century AIM VCT Sareum (LON:SAR) and Proactis (LON:PHD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, community ranking, media sentiment and analyst recommendations. Does the media favor SAR or PHD? In the previous week, Sareum's average media sentiment score of 0.00 equaled Proactis'average media sentiment score. Company Overall Sentiment Sareum Neutral Proactis Neutral Which has higher earnings and valuation, SAR or PHD? Proactis has higher revenue and earnings than Sareum. Sareum is trading at a lower price-to-earnings ratio than Proactis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSareumN/AN/A-£5.28M-£4.22-3.39Proactis£48.90M0.00N/A-£20.70N/A Is SAR or PHD more profitable? Proactis' return on equity of 0.00% beat Sareum's return on equity.Company Net Margins Return on Equity Return on Assets SareumN/A -270.25% -113.80% Proactis N/A N/A N/A Does the MarketBeat Community prefer SAR or PHD? Proactis received 91 more outperform votes than Sareum when rated by MarketBeat users. However, 66.13% of users gave Sareum an outperform vote while only 55.10% of users gave Proactis an outperform vote. CompanyUnderperformOutperformSareumOutperform Votes8266.13% Underperform Votes4233.87% ProactisOutperform Votes17355.10% Underperform Votes14144.90% SummaryProactis beats Sareum on 4 of the 7 factors compared between the two stocks. Get Sareum News Delivered to You Automatically Sign up to receive the latest news and ratings for SAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SAR vs. The Competition Export to ExcelMetricSareumBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£17.87M£126.08M£5.57B£2.91BDividend Yield1.10%3.74%5.27%4.90%P/E Ratio-3.393.2526.78124.60Price / SalesN/A4,108.15404.49248,064.90Price / Cash11.3213.1938.2528.07Price / Book5.4835.866.964.64Net Income-£5.28M-£91.56M£3.23B£5.91B7 Day Performance-0.69%0.31%-1.24%12.86%1 Month Performance-12.00%6.18%8.34%25.97%1 Year Performance-62.37%178.38%33.30%77.96% Sareum Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SARSareumN/AGBX 14.30+2.1%N/A-63.8%£17.87MN/A-3.393,211PHDProactisN/AN/AN/AN/A£70.69M£48.90M-3.57516FENFrenkel Topping GroupN/AGBX 48.20-0.6%N/A+0.5%£59.05M£34.56M56.16307Gap DownNMTNeometalsN/AN/AN/AN/A£57.39MN/A-1.87N/ATSITwo Shields Investments Plc (TSI.L)N/AN/AN/AN/A£6.15MN/A-1.053CGOContangoN/AGBX 0.85+3.0%N/A+8.9%£6.15MN/A-85.002,219Gap DownMYNMayan EnergyN/AN/AN/AN/A£5.28M-£3K-0.235Gap UpIDEIDE GroupN/AN/AN/AN/A£3.60M£13.64M-18.13237EVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010PCFPCF GroupN/AN/AN/AN/A£3.17M£19.54M-0.79125Positive NewsGap DownHigh Trading VolumeNCANew Century AIM VCTN/AN/AN/AN/A£2.00M-£2.76M-68.92N/A Related Companies and Tools Related Companies Proactis Competitors Frenkel Topping Group Competitors Neometals Competitors Two Shields Investments Plc (TSI.L) Competitors Contango Competitors Mayan Energy Competitors IDE Group Competitors Evgen Pharma Competitors PCF Group Competitors New Century AIM VCT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SAR) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredOil Hits $74 - $100 Next?Oil Jumps 8.5% on Middle East Crisis Trump at Oil Fields Oil surged 8.5% to $74/barrel after Israel's Ir...The Oxford Club | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sareum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
